Keyphrases
Histoplasmosis
37%
Epidemiology
37%
Solid Organ Transplant Recipients
35%
Confidence Interval
32%
Rheumatoid Arthritis
30%
Fungal Infection
25%
Fluconazole
24%
Invasive Fungal Infection
24%
COVID-19
22%
Infective Endocarditis
22%
Sepsis
22%
Transplant Recipients
21%
Anti-tumor Necrosis Factor Therapy
20%
Cryptococcosis
19%
Autoimmune Disease
18%
Herpes Zoster
18%
United States
16%
Cryptococcal Meningitis
16%
Candidemia
16%
Amphotericin B
15%
Immunocompromised Patients
14%
AIDS/HIV
14%
Invasive Fungal Disease
14%
Racial Differences
13%
Geographical Differences
13%
Infectious Diseases
13%
Risk Factors
13%
Biologic Therapy
13%
Incidence Rate
13%
Clinical Features
13%
Non-biologic
13%
Clinical Outcomes
12%
Cryptococcus Neoformans
12%
Antifungal Therapy
12%
Opportunistic Infections
12%
Systemic Juvenile Idiopathic Arthritis (sJIA)
12%
Inflammatory Diseases
12%
Invasive Aspergillosis
11%
Infection Rate
11%
Solid Organ Transplantation
11%
Transplantation
11%
Rheumatoid Arthritis Patients
11%
Itraconazole
11%
Hospital-acquired Infection
11%
Disease-modifying Antirheumatic Drugs (DMARDs)
11%
Posttransplant Infection
11%
Antifungal Susceptibility
10%
Tumour Necrosis Factor Inhibitor (TNFi)
10%
Invasive Candidiasis
10%
HIV Patients
10%
Medicine and Dentistry
Infection
84%
Transplantation
56%
Mycosis
44%
Disease
40%
Human Immunodeficiency Virus
32%
Infective Endocarditis
32%
Cohort Effect
31%
Immunocompromised Patient
26%
COVID-19
24%
Systemic Mycosis
24%
Disseminated Herpes Zoster
22%
Cryptococcosis
21%
Endocarditis
20%
Apoplexy
19%
Biological Therapy
18%
Rheumatoid Arthritis
17%
Histoplasmosis
17%
Sepsis
15%
Cryptococcal Meningitis
13%
Invasive Aspergillosis
12%
Antifungal Therapy
12%
Prospective Cohort Study
12%
Opportunistic Infection
12%
Fluconazole
12%
Amphotericin B
11%
Diagnosis
11%
Clinical Feature
10%
Antifungal Agent
10%
Surgery
10%
Inflammatory Disorder
10%
Pathogen
9%
Immunosuppressive Treatment
9%
Race Difference
9%
Central Nervous System
9%
Bloodstream Infection
8%
Autoimmune Disease
8%
Mucormycosis
8%
Clinical Management
8%
Biological Product
8%
Tumor Necrosis Factor
7%
Solid Organ Transplantation
7%
Itraconazole
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Silo-Filler's Disease
7%
Observational Study
7%
Coccidioidomycosis
7%
Varicella Zoster Vaccine
7%
Bacteremia
6%
Intensive Care Unit
6%
TNF Inhibitor
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Disease
43%
Rheumatoid Arthritis
39%
Histoplasmosis
29%
Biological Product
28%
HIV
26%
Herpes Zoster
22%
Antifungal Agent
22%
Systemic Mycosis
21%
Bacterial Endocarditis
21%
Tumor Necrosis Factor
20%
Antifungal Therapy
19%
Mycosis
18%
Tumor Necrosis Factor Inhibitor
18%
Autoimmune Disease
18%
Sepsis
16%
Vaccination Policy
15%
Candida
14%
Fluconazole
13%
Immunocompromised Patient
12%
Invasive Candidiasis
12%
Amphotericin B
12%
Endocarditis
11%
Opportunistic Infection
11%
Prospective Cohort Study
11%
Inflammatory Disease
11%
Invasive Aspergillosis
10%
Disease Modifying Antirheumatic Drug
10%
Cohort Study
10%
Mould
10%
Candidemia
10%
Itraconazole
10%
Juvenile Rheumatoid Arthritis
9%
Bacteremia
9%
Aspergillus
8%
Bloodstream Infection
8%
Infectious Agent
8%
Cryptococcal Meningitis
8%
Etanercept
8%
Pharmacotherapy
7%
Histoplasma
7%
Observational Study
7%
Aspergillosis
7%
Varicella Zoster Vaccine
7%
Psoriasis
6%
Malignant Neoplasm
6%
Voriconazole
6%
Infliximab
6%
Bacterial Infection
6%
Adverse Event
6%
